DF
LABU icon

Dunhill Financial’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Dunhill Financial’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-360
Closed -$20.5K – 1003
2025
Q2 		$20.5K Hold
360
– – 0.01% 331
2025
Q1 		$21.9K Hold
360
– – 0.01% 287
2024
Q4 		$32.4K Hold
360
– – 0.02% 223
2024
Q3 		$46.3K Buy
+360
New +$47K 0.02% 174

Other funds holding LABU

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
IMC Chicago
IMC Chicago Chicago, Illinois $278B AUM 44.93% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JF
Jump Financial Chicago, Illinois $7.5B AUM 33.9% 1-Year Est. Return

Dunhill Financial's LABU Position: Q3 2025 in Review

Dunhill Financial sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q3 2025, closing a stake of 360 shares — an estimated $20.5K sold.

Dunhill Financial first reported a position in LABU in Q3 2024 and held it in 4 quarters. The position peaked at $46.3K in Q3 2024. 39 funds tracked by Wall St. Rank hold LABU as of Q3 2025.

  • Dunhill Financial reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q3 2025 after selling out during the quarter.
  • Dunhill Financial sold 360 Direxion Daily S&P Biotech Bull 3X ETF shares in Q3 2025, an estimated $20.5K.
  • Dunhill Financial first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q3 2024 and held it in 4 quarters.
  • Dunhill Financial's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $46.3K in Q3 2024.
  • 39 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q3 2025.

Based on Dunhill Financial's 13F filing for Q3 2025, filed 12 Nov 2025.